Song Ju Sun, Kang Jong-Sun, Kim Young-Eun, Park Seung-Jung, Park Kyoung-Min, Huh June, Kim June Soo, Cho Hana, Ki Chang-Seok, On Young Keun
Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.
J Hum Genet. 2017 Jun;62(6):615-620. doi: 10.1038/jhg.2017.8. Epub 2017 Feb 16.
Pathogenic variants in genes related to channelopathy and cardiomyopathy are the most common cause of sudden unexplained cardiac death. However, few reports have investigated the frequency and/or spectrum of pathogenic variants in these genes in Korean sudden cardiac arrest survivors. This study aimed to investigate the causative genetic variants of cardiac-associated genes in Korean sudden cardiac arrest survivors. We performed exome sequencing followed by filtering and validation of variants in 100 genes related to channelopathy and cardiomyopathy in 19 Korean patients who survived sudden cardiac arrest. Five of the 19 patients (26.3%) had either a pathogenic variant or a likely pathogenic variant in MYBPC3 (n=1), MYH7 (n=1), RYR2 (n=2), or TNNT2 (n=1). All five variants were missense variants that have been reported previously in patients with channelopathies or cardiomyopathies. Furthermore, an additional 12 patients (63.2%) had more than one variant of uncertain significance. In conclusion, pathogenic or likely pathogenic variants in genes related to channelopathy and cardiomyopathy are not uncommon in Korean sudden cardiac arrest survivors and cardiomyopathy-related genes should be included in the molecular diagnosis of sudden cardiac arrest in Korea.
与通道病和心肌病相关基因的致病性变异是不明原因心脏性猝死的最常见原因。然而,很少有报告调查这些基因的致病性变异在韩国心脏骤停幸存者中的频率和/或谱系。本研究旨在调查韩国心脏骤停幸存者中与心脏相关基因的致病基因变异。我们对19名韩国心脏骤停幸存者进行了外显子组测序,随后对与通道病和心肌病相关的100个基因中的变异进行了筛选和验证。19名患者中有5名(26.3%)在MYBPC3(n = 1)、MYH7(n = 1)、RYR2(n = 2)或TNNT2(n = 1)中有致病性变异或可能致病性变异。所有五个变异均为错义变异,此前已在通道病或心肌病患者中报道。此外,另有12名患者(63.2%)有一个以上意义未明的变异。总之,与通道病和心肌病相关基因的致病性或可能致病性变异在韩国心脏骤停幸存者中并不罕见,与心肌病相关的基因应纳入韩国心脏骤停的分子诊断中。